Gammon India accepts resignation of independent director Vishwas Joglekar
- Gammon India accepted resignation of Independent Director Vishwas Madhusudan Joglekar
- Resignation effective September 9, 2026 due to social service commitments
- Company filed intimation under SEBI Regulation 30 on September 10, 2026
- No other material reasons cited for the departure

*this image is generated using AI for illustrative purposes only.
Gammon India Limited (NSE: GAMMONIND) accepted the resignation of Vishwas Madhusudan Joglekar from the position of Non-Executive Independent Director. The cessation is effective September 9, 2026.
The company disclosed the development in a filing to the National Stock Exchange of India Limited and BSE Limited on September 10, 2026. The move follows a resignation letter dated September 9, 2026, submitted by Mr. Joglekar to the Board of Directors.
Reason for Resignation
Mr. Joglekar cited his pre-occupation in social service activities as the reason for stepping down. In his resignation letter, he confirmed that there are no other material reasons for his departure from the role.
He expressed appreciation for the support extended by the Board of Directors, management, and stakeholders during his tenure. The company requested the exchanges to record the information pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015.
Board Composition Update
Vemparala Dakshinamurty, Whole Time Director and Chairman of Gammon India, signed the intimation letter. The disclosure confirms that Mr. Joglekar does not hold directorships in other listed entities at the time of resignation.
The company’s registered office remains at Hamilton House, Ballard Estate, Mumbai.
Has Gammon India initiated the search for a new Non-Executive Independent Director to replace Mr. Joglekar, and what is the expected timeline for appointment?
How will the departure of an independent director impact Gammon India's board governance structure and compliance with SEBI's listing regulations?
Are there any pending strategic decisions or audit committee responsibilities that require immediate attention due to this change in board composition?

































